Skip to content

Clinical trials

Completed Attention Deficit Disorder with Hyperactivity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Status: Completed Country / region: Germany Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20051
20062
20073
20087
20092
20104
20114
20126
20131
20163
20171
20182
20193
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire10
Eli Lilly and Company8
Medice Arzneimittel Pütter GmbH & Co KG4
Boehringer Ingelheim2
Janssen-Cilag International NV2
Novartis2
Novartis Pharmaceuticals2
University Hospital Tuebingen2
University of Cologne2
Central Institute of Mental Health, Mannheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity50
Borderline Personality Disorder3
Anxiety Disorders2
Mental Disorders2
Oppositional Defiant Disorder2
Spasm2
Color Vision Defects1
Compulsive Personality Disorder1
Depressive Disorder1
Obesity1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.